ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today that it has determined the pricing for an offering of shares and warrants. The Company intends to sell 2,250,000 shares of common stock at $2.00 per share and warrants to purchase an aggregate of 1,125,000 shares of common stock at a price of $2.64 per share. Houlihan Lokey Capital, Inc. acted as the exclusive placement agent for the offering.
The shares and warrants are being offered pursuant to the Company's effective registration statement on Form S-3 filed with the Securities and Exchange Commission (SEC) on January 6, 2011. The shares and warrants may be offered only by means of a prospectus. The shares of common stock and warrants are immediately separable and will be issued separately. The warrants will not be exercisable prior to six months after issuance and will be exercisable for a period of five years after the closing of the transaction. The closing of the offering is expected to take place on March 9, 2011, subject to usual and customary closing conditions.